News

Investigators report promising results from phase 2 study of targeted therapy for rare bile duct cancer

Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic target

Scientists uncover 'mix and match' mechanism for creating new cancer-fighting drugs

A portable ultrasound system could make reliable breast imaging more accessible

Gut microbiome: The hidden architect of liver cancer immunotherapy response

Parsing the pathology of prostate cancer

AI-guided pathology analysis can help predict immunotherapy response in rare cancers

Uncovering gene-based clues to how disrupted healing in stomach cells increases cancer risk

TIM-3 checkpoint blockade enhances CAR-T activity against solid tumours

Study reveals how leukaemia cells enter and damage lungs

PLXNC1 – a novel biomarker for consensus molecular subtype 4 in colorectal cancer (CMS4 CRC)

New laboratory tool opens door to better treatments for rare and deadly melanomas